Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New limpet device aims to stop ostomy leaks and skin woes

NCT ID NCT06524401

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a new device called Limpet, which uses gentle suction to keep the area around an ostomy clean and dry. About 92 adults who have had ileostomy surgery or have a high-output fistula will either get the Limpet or standard adhesive pouches. Researchers will check for skin problems and leaks over 30 days to see if the Limpet works better.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Limpet device (negative pressure wound therapy system)
What this could lead to
If it works, this could give people with ostomies a more reliable, less leaky way to manage their surgical opening, reducing skin irritation and hospital visits.
What could go wrong
This is a small, early-stage trial with only 92 participants, so results may not apply to everyone. The device may not be more effective than standard care, and some people may find it uncomfortable or difficult to use at home.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 92 people

The number the study aims to enrol. It can still change while the study runs.

Started

Nov 2024

Expected to finish

Mar 2029

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Participant is greater than 18 years of age, inclusive * Participant is undergoing ileostomy surgery or, * has an enterocutaneous fistula with output over 500cc in 24 hours * Participants stoma will have a maximum diameter of 1.5 inches based on measurements from the Investigator or Sponsor. * Area around the stoma must have no injury through the dermis (i.e., intact skin) * Participant is willing and able to comply with all protocol-specified requirements * Participant is capable of reading and understanding English and will provide written informed consent to participate. Exclusion Criteria: * Unable/unwilling to attend the follow-up appointments * Participant has a life expectancy \< 30 days. * Participant has a stature too small for use of the Limpet in the opinion of the Investigator or Sponsor. * Participant has an enteroatmospheric fistula (enteric fistula to an open wound) * Participant is scheduling/planning concurrent chemotherapy or other radiation treatment during the study follow-up period * Participant has a history of sensitivity or allergy to hydrocolloids or other materials in the Limpet device. * Participant is pregnant or planning to become pregnant (verbal report). * Participant is unable or unwilling to provide informed consent. * Participant is currently participating in an investigational drug or another device study that clinically interferes with the current study endpoints. * Participant has any other disease or medical condition that, in the opinion of the Investigator or Sponsor, could endanger the participant, interfere with the evaluation of the study device's efficacy or safety, or compromise the participant's ability to comply with/complete the study.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Enterocutaneous fistula are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Regions Hospital

    RECRUITING

    Saint Paul, Minnesota, 55101, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.